Find clinical trials for Lymphoma in Columbus, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Columbus, OH, USA:
of rituximab and epcoritamab is in treating patients with Follicular Lymphoma (FL) and who have not received other treatments for their lymphoma...
Phase 2
Columbus, Ohio, United States and 2 other locations
DS-3201b is an experimental drug that is being investigated in clinical research.Adults with non-Hodgkin lymphoma (NHL) may be able to join ...
Phase 1
Columbus, Ohio, United States and 20 other locations
and ibrutinib in patients with previously treated mantle cell lymphoma to evaluate the efficacy of this combination, with the primary object...
Phase 2
Columbus, Ohio, United States and 8 other locations
Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...
Phase 3
Columbus, Ohio, United States and 66 other locations
Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...
Phase 1, Phase 2
Columbus, Ohio, United States and 31 other locations
in participants with relapsed or refractory (R/R) CD30-expressing lymphomas.GEN3017 will be administered via subcutaneous injections.All par...
Phase 1, Phase 2
Columbus, Ohio, United States and 5 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Columbus, Ohio, United States and 70 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Columbus, Ohio, United States and 215 other locations
A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...
Phase 2
Columbus, Ohio, United States and 94 other locations
chimeric antigen receptor (CAR) T cell therapy for non-Hodgkins lymphoma and in whom have had a sub-optimal response early on to CAR T-cell ...
Phase 1
Columbus, Ohio, United States
Clinical trials
Research sites
Resources
Legal